Alethio Therapeutics
Alethio Therapeutics is a Healthcare & Life Sciences startup based in the United Kingdom, most recent round Seed, 2 tracked investors.
About Alethio Therapeutics
Alethio Therapeutics is a startup based in the United Kingdom. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Alethio Therapeutics is a biopharmaceutical company focused on developing precision therapies for myeloproliferative neoplasms (MPNs), a group of chronic, incurable blood cancers. The company utilizes its ARTEMIS discovery engine to identify and validate novel targets and develop first-in-class antibody-drug conjugate (ADC) therapies aimed at modifying disease progression.
Explore Alethio Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.